HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TGFbeta-induced RhoA activation and fibronectin production in mesangial cells require caveolae.

Abstract
Glomerular sclerosis of diverse etiologies is characterized by mesangial matrix accumulation, with transforming growth factor-beta (TGFbeta) an important pathogenic factor. The GTPase RhoA mediates TGFbeta-induced matrix accumulation in some settings. Here we study the role of the membrane microdomain caveolae in TGFbeta-induced RhoA activation and fibronectin upregulation in mesangial cells (MC). In primary rat MC, TGFbeta1 time dependently increased RhoA and downstream Rho kinase activation. Rho pathway inhibition blocked TGFbeta1-induced upregulation of fibronectin transcript and protein. TGFbeta1-induced RhoA activation was prevented by disrupting caveolae with cholesterol depletion and rescued by cholesterol repletion. Compared with wild types, RhoA/Rho kinase activation was absent in MC lacking caveolae. Reexpression of caveolin-1 (and caveolae) restored these responses. Phosphorylation of caveolin-1 on Y14, effected by Src kinases, has been implicated in signaling responses. Overexpression of nonphosphorylatable caveolin-1 Y14A prevented TGFbeta1-induced RhoA activation. TGFbeta1 also activated Src, and its inhibition blocked RhoA activation. Furthermore, TGFbeta1 led to association of RhoA and caveolin-1. This was prevented by Src or TGFbeta receptor I inhibition, and by caveolin-1 Y14A overexpression. Last, fibronectin upregulation by TGFbeta1 was blocked by Src inhibition, not seen in caveolin-1 knockout MC, and restored by caveolin-1 reexpression in the latter. TGFbeta1-induced collagen I accumulation also required caveolae. TGFbeta1-mediated Smad2/3 activation, however, did not require caveolae. We conclude that RhoA/Rho kinase mediates TGFbeta-induced fibronectin upregulation. This requires caveolae and caveolin-1 interaction with RhoA. Interference with caveolin/caveolae or RhoA signaling thus represents a potential target for the treatment of fibrotic renal disease.
AuthorsFangfang Peng, Baifang Zhang, Dongcheng Wu, Alistair J Ingram, Bo Gao, Joan C Krepinsky
JournalAmerican journal of physiology. Renal physiology (Am J Physiol Renal Physiol) Vol. 295 Issue 1 Pg. F153-64 (Jul 2008) ISSN: 1931-857X [Print] United States
PMID18434385 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibronectins
  • Indoles
  • Receptors, Transforming Growth Factor beta
  • SU 6656
  • Sulfonamides
  • Transforming Growth Factor beta
  • rho-Associated Kinases
  • rhoA GTP-Binding Protein
Topics
  • Animals
  • Caveolae (physiology)
  • Enzyme Activation
  • Fibronectins (biosynthesis)
  • Indoles (pharmacology)
  • Mesangial Cells (physiology)
  • Mice
  • Mice, Knockout
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Transforming Growth Factor beta (physiology)
  • Sulfonamides (pharmacology)
  • Transforming Growth Factor beta (physiology)
  • Up-Regulation
  • rho-Associated Kinases (physiology)
  • rhoA GTP-Binding Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: